EN DE

Good Fellow Healthcare Holdings Ltd (8143) Fair Value & Analysis

Healthcare · HK · Market cap HK$82.3M

GF Good Fellow Healthcare Holdings Ltd 8143 · HK
PriceHK$0.0570
Fair ValueHK$0.0425
Upside-25.4%
Quality43/100
Watch Good Fellow Healthcare Holdings Ltd for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -62.4% net margin
Low debt · generates free cash flow
Mixed vs. peers (4/10)
Narrow moat 0/100
Evidence: Low Range HK$0.0357 – HK$0.0459 Share as image

Fair value as of: Aug 13, 2026

From 7 valuation models · updated 3 days ago

Share price −18.6% over the past month.

Below-average quality, and screening another 25% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (HK$0.0459). The favourable scenario is already priced in.
  • Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

HK$0.4600 HK$0.0450 Fair Value HK$0.0425 Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range HK$0.0450 – HK$0.4600 · fair‑value band HK$0.0357 – HK$0.0459 · the HK$0.0570 price screens above the HK$0.0425 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Good Fellow Healthcare Holdings Ltd (8143) currently trades at HK$0.0570, while our model-based Fair Value estimate is HK$0.0425, implying the stock looks roughly 25.4% overvalued today. The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Good Fellow Healthcare Holdings Ltd generated revenue of HK$20.1M at a net margin of -62.4%. Revenue grew 68.2% year over year. The balance sheet holds a net cash position of HK$12.9M. Fundamentals as of Aug 13, 2026

Our scenario range runs from HK$0.0357 (bear case) to HK$0.0459 (bull case); at HK$0.0570, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 80% below its 52-week high and 33% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -25%, 8143 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF HK$0.0300 HK$0.0300 HK$0.0400 80
Rev-Margin DCF HK$0.0300 HK$0.0400 HK$0.0500 74
NCAV (Graham) HK$0.0100 50
All 7 models by family
DCF Models
FCF DCF HK$0.0300 HK$0.0300 HK$0.0400 38
5Y Revenue Exit HK$0.0300 HK$0.0400 HK$0.0500 39
10Y Revenue Exit HK$0.0300 HK$0.0300 HK$0.0400 36
Multiples
EV/Revenue HK$0.0300 HK$0.0400 HK$0.0500 43
Asset-Based
NCAV (Graham) HK$0.0100 50
Growth DCF
Growth DCF HK$0.0300 HK$0.0300 HK$0.0400 80
Rev-Margin DCF HK$0.0300 HK$0.0400 HK$0.0500 74

Widest divergence: Multiples (HK$0.0400) versus DCF Models (HK$0.0300). Highest evidence: Growth DCF (80).

Notify me when 8143 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) HK$20.1M
Revenue growth (YoY) +68.2%
Net margin -62.4%
Return on equity -2,221%
Free cash flow HK$2.6M FY2025
Operating margin -38.4%
More key figures
EPS (TTM) HK$-0.0300
Net cash HK$12.9M FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 43/100

Of which business quality 47 · Market factors (momentum, volatility) 15

Profitability 26
Margins and returns on capital today
Quality Growth 52
Are margins and returns improving?
Cashflow 70
Earnings quality: real cash, not paper profit
Fin. Strength 44
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 48
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 3
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China. Its general hospital services include medical and surgical wards, and medical checkup and examination. The company also offers medical investment and hospital management services.

Full company description

Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China. Its general hospital services include medical and surgical wards, and medical checkup and examination. The company also offers medical investment and hospital management services. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. Good Fellow Healthcare Holdings Limited was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Good Fellow Healthcare Holdings Ltd reported revenue of HK$20.1M in FY2026 versus HK$54.2M in FY2022, a compound −22.0%/yr. Reported net income was −HK$12.5M in FY2026.

Growth Quality 29/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2026)
HK$20.1M
Latest YoY
+24.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−28.7%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−17.9%
Avg. growth/yr (24Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.1%
Revenue −22.0%/yr
FY22 HK$54.2M
FY23 HK$55.4M
FY24 HK$39.0M
FY25 HK$16.1M
FY26 HK$20.1M
Net income
FY22 −HK$12.7M
FY23 −HK$5.9M
FY24 −HK$17.1M
FY25 −HK$10.1M
FY26 −HK$12.5M

8143 screens 25% overvalued. Compare with HCA Healthcare, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Good Fellow Healthcare Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/8143

Peer Group

Medical Care Facilities · 266 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 43 · Bottom 25%
Fair Value upside −25% · Below median
Return on assets -23% · Bottom 25%
Net margin (TTM) -62% · Bottom 25%
Operating margin (TTM) -38% · Bottom 25%
Revenue growth 68% · Top 25%

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/B 1.29× · Cheaper than median
P/S (TTM) 0.52× · Cheaper than median
P/FCF 4.1× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 26
FUTURE 100 · sector 23
PAST 0 · sector 29
HEALTH 100 · sector 90
DIVIDEND 0 · sector 41

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Compare Good Fellow Healthcare Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Good Fellow Healthcare Holdings Ltd (8143) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of HK$0.0425 versus a price of HK$0.0570, about −25% (overvalued).
What is the fair value of 8143?
Our model-based fair value for Good Fellow Healthcare Holdings Ltd is HK$0.0425 (as of Aug 13, 2026), built from audited fundamentals. The current price is HK$0.0570.
What is the quality score of 8143?
Good Fellow Healthcare Holdings Ltd has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Good Fellow Healthcare Holdings Ltd (8143)?
Good Fellow Healthcare Holdings Ltd reported trailing-twelve-month revenue of about HK$20.1M (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 8143?
The net profit margin of Good Fellow Healthcare Holdings Ltd is about -62.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Good Fellow Healthcare Holdings Ltd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.